Ensign Peak Advisors, Inc Haemonetics Corp Transaction History

Ensign Peak Advisors, Inc

$56.1 Billion
Q3 2024

A detailed history of Ensign Peak Advisors, Inc transactions in Haemonetics Corp stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 14,566 shares of HAE stock, worth $1.25 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,566

Previous 14,566 -0.0%

Holding current value

$1.25 Million

Previous $1.21 Million 2.9%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$71.24 - $85.35 $52,361 - $62,732	-735 Reduced 4.8%	14,566 $1.24 Million
Q4 2023 Feb 14, 2024	BUY	$80.59 - $92.61 $76,560 - $87,979	950 Added 6.62%	15,301 $1.31 Million
Q1 2023 May 15, 2023	BUY	$72.75 - $90.6 $14,550 - $18,120	200 Added 1.41%	14,351 $1.19 Million
Q4 2022 Feb 13, 2023	SELL	$73.85 - $86.14 $184,625 - $215,350	-2,500 Reduced 15.01%	14,151 $1.11 Million
Q3 2022 Nov 14, 2022	SELL	$63.3 - $78.66 $12,027 - $14,945	-190 Reduced 1.13%	16,651 $1.23 Million
Q4 2021 Feb 11, 2022	SELL	$49.55 - $74.59 $1.22 Million - $1.83 Million	-24,530 Reduced 59.29%	16,841 $893,000
Q1 2021 May 12, 2021	SELL	$111.01 - $139.48 $1.11 Million - $1.39 Million	-9,993 Reduced 19.46%	41,371 $4.59 Million
Q4 2020 Feb 12, 2021	SELL	$88.75 - $119.95 $115,375 - $155,935	-1,300 Reduced 2.47%	51,364 $6.1 Million
Q1 2020 May 11, 2020	BUY	$74.34 - $121.82 $638,803 - $1.05 Million	8,593 Added 19.5%	52,664 $5.25 Million
Q4 2019 Feb 14, 2020	BUY	$114.37 - $129.46 $5.04 Million - $5.71 Million	44,071 New	44,071 $5.06 Million

Others Institutions Holding HAE

# of Institutions

333

Shares Held

54M

Call Options Held

689K

Put Options Held

345K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.39B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Account

Ensign Peak Advisors, Inc Haemonetics Corp Transaction History